Tech Company Financing Transactions

Dxcover Funding Round

On 2/1/2023, Dxcover landed $11.7 million in Series A investment from Eos Advisory, Mercia Fund Management and Norcliffe Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

Suite RC534, Royal College Building 204 George Street
Glasgow, G1 1XW
SC

Phone

01415484700

Website

www.dxcover.com

Email Address

Undisclosed

Overview

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers.?Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Hegarty

        

Browse more venture capital transactions:

Prev: 2/1/2023: Healistic venture capital transaction
Next: 2/1/2023: Maya Climate venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary